Alector (ALEC) Invested Capital (2023 - 2026)
Alector's (ALEC) quarterly Invested Capital came in at -$122000.0 in Q2 2026, down 100.15% year-over-year from $80.7 million in Q2 2025, and down 100.56% quarter-over-quarter from $21.6 million in Q1 2026.
Analysis
Alector (ALEC) Invested Capital (2023 - 2026) Analysis & Trends
Alector (ALEC) has reported Invested Capital for 4 consecutive years, with -$122000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Invested Capital fell 100.15% year-over-year to -$122000.0 in Q2 2026; TTM through Jun 2026 was -$122000.0, a 100.15% decrease from a year earlier, with the FY2025 full-year figure at $40.7 million, down 70.11% from the prior year.
- Invested Capital was -$122000.0 for Q2 2026 at Alector, down from $21.6 million in the prior quarter.
- Over five years, Invested Capital peaked at $136.2 million in Q4 2024 and troughed at -$122000.0 in Q2 2026.
- A 4-year average of $73.1 million and a median of $74.0 million in 2025 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital gained 1.51% in 2024 and slumped 100.15% in 2026, its largest moves.
- Over 4 years, Invested Capital stood at $134.2 million in 2023, then gained by 1.51% to $136.2 million in 2024, then sank by 70.11% to $40.7 million in 2025, then slumped by 100.3% to -$122000.0 in 2026.
- The last three Invested Capital figures came in at -$122000.0 (Q2 2026), $21.6 million (Q1 2026), and $40.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 74.44 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 40.49 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 33.70 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 7.35 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 26.94 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -122,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -122,000.00 |
| Mar 31, 2026 | 21.63 Mn |
| Dec 31, 2025 | 40.70 Mn |
| Sep 30, 2025 | 67.32 Mn |
| Jun 30, 2025 | 80.71 Mn |
| Mar 31, 2025 | 104.07 Mn |
| Dec 31, 2024 | 136.19 Mn |
| Dec 31, 2023 | 134.16 Mn |